Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Solasto Corporation (6197:JPX), powered by AI.
Solasto Corporation is currently trading at ¥1,111. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Solasto Corporation on Alpha Lenz.
Solasto Corporation's P/E ratio is 25.9.
“Solasto Corporation trades at a P/E of 25.9 (premium valuation) with strong ROE of 18.3%.”
Ask for details →Solasto Corporation is a prominent player in the healthcare and nursing industry in Japan. It primarily focuses on providing medical-related services, care services, and human resource services, facilitating a comprehensive approach to healthcare management. Solasto operates in various segments, including medical outsourcing services, where it assists hospitals and clinics by managing administrative tasks such as medical reception, accounting, and clerical jobs. Additionally, the company plays a crucial role in the elderly care sector by offering in-home and facility-based services, catering to Japan's aging population. In human resources, Solasto supports the healthcare industry with staffing solutions that ensure qualified personnel are placed in necessary positions. The corporation's significance in the market is underscored by its contribution to enhancing efficiency and quality in healthcare services while addressing the growing demands of elder care in Japan's demographic landscape. Founded in 1965 and headquartered in Tokyo, Solasto Corporation continues to impact the healthcare service continuum, ensuring operational reliability through innovation and comprehensive service delivery.
“Solasto Corporation trades at a P/E of 25.9 (premium valuation) with strong ROE of 18.3%.”
Ask for details →Solasto Corporation (ticker: 6197) is a company listed on JPX in the Healthcare sector (Medical Care Facilities). It has approximately 33,616 employees. Market cap is $102.5B.
The current price is 1,111 with a P/E ratio of 25.88x and P/B of 4.52x.
ROE is 18.35% and operating margin is 5.11%. Annual revenue is $137.4B.